|
Three major activities
of
RPG
Life Sciences Limited are:
-
Manufacturing
and marketing of bulk drugs (synthetic Active Pharmaceutical Ingredients)
& formulations internationally [SBU- I],
-
Pharmaceutical formulations & Domestic
Marketing [SBU – II] and
-
Fermentation & biotechnology
[SBU – III].
RPGLS is present in the domestic as well as the international markets. It
exports its products primarily to Europe, Latin America, Africa,
Australia, CIS Nations & South East Asian countries.
Earlier
known as Searle India Ltd, RPGLS started in 1968 as a joint venture with
GD Searle, USA. In 1993, GD Searle withdrew from India and sold its
holdings to RPG Group. The company’s name was changed to RPG Life
Sciences Ltd effective 1st April 1999. The company was in the business of
Pharmaceuticals and Agrochemicals. It divested the Agrochemicals business
in the year 2001, as per the strategic decision to focus on
Pharmaceuticals, Fermentation and Biotechnology.
RPGLS employs
750 people. It is
a multi-location pharmaceutical manufacturing company with 4 locations.
Manufacturing unit at Thane produces Active Pharmaceuticals Ingredients
(also called as Bulk Drugs) and is ISO 9001 certified and has Therapeutic
Goods Administration (TGA), Australia, and approval for 3 of its major
products namely Diphenoxylate Hydrochloride,
Haloperidol and Propanthelene Bromide.
The Formulation Plant at Ankleshwar GIDC manufactures pharmaceuticals
formulations for Domestic as well as for exports and is ISO 9002 and
ISO14001 certified. The site also has MHRA (Medicines and Healthcare
products Regulatory Agency, UK) approved plant for catering to its Global
Generic business.
The second Plant at Ankleshwar makes API through Fermentation
route to cater to the Biotech Business.
|
